<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1772">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05138094</url>
  </required_header>
  <id_info>
    <org_study_id>NP3969</org_study_id>
    <nct_id>NCT05138094</nct_id>
  </id_info>
  <brief_title>LIVACOR Trial: Minimally Invasive LIVer And Simultaneous COlorectal Resection</brief_title>
  <acronym>LIVACOR</acronym>
  <official_title>LIVACOR Trial: Minimally Invasive LIVer And Simultaneous COlorectal Resection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondazione Poliambulanza Istituto Ospedaliero</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Amsterdam UMC</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Southampton NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Birmingham NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Liverpool University Hospitals NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>King's College Hospital NHS Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Manchester University NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Newcastle-upon-Tyne Hospitals NHS Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Plymouth NHS Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mauriziano Umberto I Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Padova</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fondazione Policlinico Universitario Agostino Gemelli IRCCS</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>San Raffaele University Hospital, Italy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ospedali Riuniti Ancona</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Usl di Bologna</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Ospedaliero-Universitaria di Modena</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Federico II University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Parma University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Klinikum Saarbrücken, Klinik für Allgemein-, Viszeral- und Thoraxchirurgie, Chirurgische Onkologie</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Navarrra Hospital (Clinica Universitaria)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital del Mar</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ziekenhuis Oost-Limburg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>General Hospital Groeninge</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Moscow Clinical Scientific Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centre Hospitalier du Luxembourg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fondazione Poliambulanza Istituto Ospedaliero</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The LIVACOR - Trial is a European wide, randomized controlled, open-label, multicenter trial.&#xD;
      Patients with synchronous colorectal liver metastases (CRLMs) and primary colorectal tumor&#xD;
      are considered eligible and will be randomized between minimally invasive (MI) combined or&#xD;
      staged colorectal resection (all colectomies, including high anterior resection) and liver&#xD;
      resection of up to three segments.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 6, 2021</start_date>
  <completion_date type="Anticipated">September 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to functional recovery</measure>
    <time_frame>Expected average of 4 to 12 days postoperatively</time_frame>
    <description>A patient is considered functionally recovered from a surgical procedure when several pre-specified criteria have been met.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>R0 resection margin</measure>
    <time_frame>30 days postoperatively</time_frame>
    <description>Proportion of patients in whom a microscopically radical resection of both the primary colorectal carcinoma and the liver metastases was performed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>30 days postoperatively</time_frame>
    <description>The length of hospital stay for the surgical procedure(s)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Activity tracking using Fitbit™</measure>
    <time_frame>14 days pre-operatively and 60 days postoperatively</time_frame>
    <description>A patient's functional recovery will also be assessed using the Fitbit smartwatch.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative blood loss</measure>
    <time_frame>During the surgical procedure</time_frame>
    <description>Intraoperative blood loss in milliliters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operative time</measure>
    <time_frame>Operative time from incision until last suture</time_frame>
    <description>Operative time in minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Morbidity</measure>
    <time_frame>90-days postoperatively</time_frame>
    <description>Morbidity related to the surgical procedure(s)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative bile leakage</measure>
    <time_frame>90-days postoperatively</time_frame>
    <description>Bile leakage occurring after the liver resection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative anastomotic leakage</measure>
    <time_frame>90-days postoperatively</time_frame>
    <description>Anastomotic leakage occurring after the colorectal resection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Conversion to open surgery</measure>
    <time_frame>During the surgical procedure</time_frame>
    <description>Intra-operative conversion to an open or hand-assisted procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Readmission rate</measure>
    <time_frame>90-days postoperatively</time_frame>
    <description>Proportion of patients who is unexpectedly readmitted after the surgical procedure(s)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health-Related Quality of Life</measure>
    <time_frame>1 year postoperatively</time_frame>
    <description>The physical, social and emotional well-being of the patient; assessed using the EuroQol 5d and European Organisation for Research and Treatment of Cancer Quality-of-life Questionnaire Core 30 instruments.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reasons for delay of discharge after functional recovery</measure>
    <time_frame>30 days postoperatively</time_frame>
    <description>All reasons that may cause delay in discharge after the patient has recovered functionally, such as administrative reasons, patient confidence, logistics problems, etc.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital and societal costs</measure>
    <time_frame>1 year postoperatively</time_frame>
    <description>All costs that are associated with the operation, including in-hospital costs and out of hospital costs, such as home care, work absence, etc.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Three and five-year recurrence free survival</measure>
    <time_frame>5 years postoperatively</time_frame>
    <description>The proportion of patients which is free of recurrence of the malignant disease after resection of both the primary colorectal carcinoma and the liver metastases.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Three and five-year overall survival</measure>
    <time_frame>5 years postoperatively</time_frame>
    <description>The proportion of patients which is alive after resection of both the primary colorectal carcinoma and the liver metastases.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">82</enrollment>
  <condition>Colorectal Neoplasms Malignant</condition>
  <condition>Neoplasm Metastasis</condition>
  <arm_group>
    <arm_group_label>Minimally invasive two-stage resection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Minimally invasive resection of the primary colorectal carcinoma and liver metastases in two stages. The liver metastases or the colorectal carcinoma can be resected during the first surgical procedure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Minimally invasive simultaneous resection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Minimally invasive resection of both the primary colorectal carcinoma and the liver metastases in one procedure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Minimally invasive simultaneous resection</intervention_name>
    <description>One minimally invasive surgical procedure wherein both the primary colorectal carcinoma and the liver metastases are removed.</description>
    <arm_group_label>Minimally invasive simultaneous resection</arm_group_label>
    <other_name>Minimally invasive combined resection</other_name>
    <other_name>Minimally invasive synchronous resection</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Minimally invasive two-stage resection</intervention_name>
    <description>Two minimally invasive surgical procedures wherein the primary colorectal carcinoma and the liver metastases are removed</description>
    <arm_group_label>Minimally invasive two-stage resection</arm_group_label>
    <other_name>Minimally invasive sequential resection</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ≥ 18 years&#xD;
&#xD;
          -  Diagnosed with primary CRC with resectable synchronous CRLMs (with or without&#xD;
             neoadjuvant chemotherapy)*&#xD;
&#xD;
          -  Elective indication for MI combined or staged colorectal resection (all colectomies,&#xD;
             including high anterior resection) and liver resection of up to 3 segments with a&#xD;
             maximum of 2 separate liver resections. The MI two-staged approach includes both the&#xD;
             conventional strategy (first resection of primary colorectal tumor followed by liver&#xD;
             resection for CRLMs) and liver-first strategy (first CRLMs resection followed by&#xD;
             resection of colorectal primary tumor). Patients undergoing bilobar resections are&#xD;
             eligible (if 3 or fewer segments are resected)&#xD;
&#xD;
          -  BMI between and including 18-35&#xD;
&#xD;
          -  Patients with American Society of Anesthesiologists (ASA) physical status I-III and&#xD;
             the American College of Surgeons national surgical quality improvement project (ACS&#xD;
             NSQIP) universal surgical risk score of ≤ 50% for serious complications&#xD;
&#xD;
               -  In case of neoadjuvant chemotherapy, time interval between last chemotherapy&#xD;
                  cycle and (first) surgery should be 4-6 weeks.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability to give (written) informed consent.&#xD;
&#xD;
          -  Patients requiring a planned temporarily or permanent stoma after colorectal resection&#xD;
             (all colectomies, including high anterior resection). Patients who will receive an&#xD;
             unplanned stoma intraoperatively, will be analysed according to their initial&#xD;
             treatment assignment.&#xD;
&#xD;
          -  Patients requiring multivisceral colorectal resection (all colectomies, including high&#xD;
             anterior resection).&#xD;
&#xD;
          -  Indication for MI combined or staged low anterior resection, total mesorectal excision&#xD;
             or abdominoperineal resection and liver resection of four or more segments (i.e.,&#xD;
             hemihepatectomy or more extensive resections).&#xD;
&#xD;
          -  Patients with peritoneal metastases.&#xD;
&#xD;
          -  Patients with ASA physical status IV-V and ACS NSQIP surgical risk score of &gt; 50% for&#xD;
             serious complications.&#xD;
&#xD;
          -  Repeat open hepatectomy&#xD;
&#xD;
          -  Surgical history of colorectal- or liver resection for neoplastic disease&#xD;
&#xD;
          -  Surgical history of major or complicated open abdominal surgery&#xD;
&#xD;
          -  Indication for concurrent thermal ablation&#xD;
&#xD;
          -  Medical history of thermal ablation of liver for malignancy&#xD;
&#xD;
          -  Unresectable extrahepatic metastases&#xD;
&#xD;
          -  Pre-operatively reconstruction of vessels/bile ducts is deemed necessary&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Professor Mohammed Abu Hilal, MD PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Fondazione Poliambulanza Istituto Ospedaliero</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jasper Sijberden, MD</last_name>
    <phone>0031630150451</phone>
    <email>jasper.sijberden@poliambulanza.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Professor Mohammed Abu Hilal, MD PhD</last_name>
    <email>abuhilal9@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ziekenhuis Oost-Limburg</name>
      <address>
        <city>Genk</city>
        <state>Limburg</state>
        <zip>3600</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dennis Wicherts, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Dennis Wicherts, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joep Knol, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>General Hospital Groeninge</name>
      <address>
        <city>Kortrijk</city>
        <state>West Flanders</state>
        <zip>8500</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mathieu D'Hondt, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Mathieu D'Hondt, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bart van Geluwe, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Antoine-Béclère Hospital</name>
      <address>
        <city>Paris</city>
        <state>Île-de-France</state>
        <zip>92140</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ibrahim Dagher, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Ibrahim Dagher, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Panagiotis Lainas, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum Saarbrücken, Klinik für Allgemein-, Viszeral- und Thoraxchirurgie, Chirurgische Onkologie</name>
      <address>
        <city>Saarbrücken</city>
        <state>Saarland</state>
        <zip>66119</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gregor Stavrou, MD</last_name>
    </contact>
    <investigator>
      <last_name>Gregor Stavrou, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Federico II University Hospital</name>
      <address>
        <city>Naples</city>
        <state>Calabria</state>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Roberto Troisi, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Roberto Troisi, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gaetano Luglio, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda USL di Bologna</name>
      <address>
        <city>Bologna</city>
        <state>Emilia-Romagna</state>
        <zip>40124</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Elio Jovine, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Elio Jovine, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michele Masetti, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Simone Nicosia, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero-Universitaria di Modena</name>
      <address>
        <city>Modena</city>
        <state>Emilia-Romagna</state>
        <zip>41125</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Fabrizio di Benedetto, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Fabrizio di Benedetto, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paolo Magistri, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Parma University Hospital</name>
      <address>
        <city>Parma</city>
        <state>Emilia-Romagna</state>
        <zip>43126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Raffaele Dalla Valle, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Raffaele Dalla Valle, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mario Giuffrida, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fondazione Policlinico Universitario Agostino Gemelli IRCCS</name>
      <address>
        <city>Roma</city>
        <state>Lazio</state>
        <zip>00168</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Felice Giuliante, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Felice Giuliante, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Roberto Persiani, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fondazione Poliambulanza Istituto Ospedaliero</name>
      <address>
        <city>Brescia</city>
        <state>Lombardy</state>
        <zip>25124</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohammed Abu Hilal, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Mohammed Abu Hilal, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jasper Sijberden, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>San Raffaele University Hospital</name>
      <address>
        <city>Milan</city>
        <state>Lombardy</state>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Luca Aldrighetti, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Luca Aldrighetti, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedali Riuniti</name>
      <address>
        <city>Ancona</city>
        <state>Marche</state>
        <zip>60126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marco Vivarelli, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Marco Vivarelli, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mario Guerrieri, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrea Benedetti Cacciaguerra, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mauriziano Umberto I Hospital</name>
      <address>
        <city>Turin</city>
        <state>Piemonte</state>
        <zip>10128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alessandro Ferrero, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Alessandro Ferrero, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paolo Massucco, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Padova</name>
      <address>
        <city>Padova</city>
        <state>Veneto</state>
        <zip>35128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Umberto Cillo, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Umberto Cillo, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Enrico Gringeri, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jacopo Lanari, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier du Luxembourg</name>
      <address>
        <city>Luxembourg</city>
        <zip>1210</zip>
        <country>Luxembourg</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Edoardo Rosso, MD</last_name>
    </contact>
    <investigator>
      <last_name>Edoardo Rosso, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier du Luxembourg</name>
      <address>
        <city>Luxembourg</city>
        <zip>L-1210</zip>
        <country>Luxembourg</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Edoardo Rosso, MD</last_name>
    </contact>
    <investigator>
      <last_name>Edoardo Rosso, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Maastricht University Medical Center</name>
      <address>
        <city>Maastricht</city>
        <state>Limburg</state>
        <zip>6229 HX</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ronald van Dam, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Ronald van Dam, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jarno Melenhorst, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Amsterdam UMC</name>
      <address>
        <city>Amsterdam</city>
        <state>Noord-Holland</state>
        <zip>1081 HV</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rutger-Jan Swijnenburg, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Rutger-Jan Swijnenburg, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oslo University Hospital</name>
      <address>
        <city>Oslo</city>
        <state>Østlandet</state>
        <zip>N-0424</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bjørn Edwin, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Bjørn Edwin, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sheraz Yaqub, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Asmund Fretland, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Moscow Clinical Scientific Center</name>
      <address>
        <city>Moscow</city>
        <state>Moscow Oblast</state>
        <zip>111123</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mikhail Efanov, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Mikhail Efanov, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mikhail Danilov, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aslan Baychorov, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital del Mar</name>
      <address>
        <city>Barcelona</city>
        <state>Catalonia</state>
        <zip>08003</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benedetto Ielpo, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Benedetto Ielpo, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Navarrra Hospital (Clinica Universitaria)</name>
      <address>
        <city>Pamplona</city>
        <state>Navarre</state>
        <zip>31008</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Fernando Rotellar, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Fernando Rotellar, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Manchester University NHS Foundation Trust</name>
      <address>
        <city>Manchester</city>
        <state>North West England</state>
        <zip>M13 9WL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Aali Sheen, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Aali Sheen, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Newcastle-upon-Tyne Hospitals NHS Trust</name>
      <address>
        <city>Newcastle</city>
        <state>Northeast England</state>
        <zip>NE1 4LP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Steve White, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Steve White, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Liverpool University Hospitals NHS Foundation Trust</name>
      <address>
        <city>Liverpool</city>
        <state>Northwest England</state>
        <zip>L7 8XP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rafael Díaz-Nieto, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Rafael Díaz-Nieto, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Southampton NHS Foundation Trust</name>
      <address>
        <city>Southampton</city>
        <state>South East England</state>
        <zip>SO16 6YD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>John Primrose, PhD</last_name>
    </contact>
    <investigator>
      <last_name>John Primrose, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alex Mirnezami, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>King's College Hospital NHS Trust</name>
      <address>
        <city>London</city>
        <state>Southeast England</state>
        <zip>SE5 9RS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Krishna Menon, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Krishna Menon, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Amyn Haji, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Plymouth NHS Trust</name>
      <address>
        <city>Plymouth</city>
        <state>Southwest England</state>
        <zip>PL6 8DH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Somaiah Aroori, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Somaiah Aroori, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Birmingham NHS Foundation Trust</name>
      <address>
        <city>Birmingham</city>
        <state>West Midlands</state>
        <zip>B15 1NT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Robert Sutcliffe, MD</last_name>
    </contact>
    <investigator>
      <last_name>Robert Sutcliffe, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shazad Ashraf, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Luxembourg</country>
    <country>Netherlands</country>
    <country>Norway</country>
    <country>Russian Federation</country>
    <country>Spain</country>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>van der Poel MJ, Tanis PJ, Marsman HA, Rijken AM, Gertsen EC, Ovaere S, Gerhards MF, Besselink MG, D'Hondt M, Gobardhan PD. Laparoscopic combined resection of liver metastases and colorectal cancer: a multicenter, case-matched study using propensity scores. Surg Endosc. 2019 Apr;33(4):1124-1130. doi: 10.1007/s00464-018-6371-1. Epub 2018 Aug 1.</citation>
    <PMID>30069639</PMID>
  </reference>
  <reference>
    <citation>Pan L, Tong C, Fu S, Fang J, Gu Q, Wang S, Jiang Z, Juengpanich S, Cai X. Laparoscopic procedure is associated with lower morbidity for simultaneous resection of colorectal cancer and liver metastases: an updated meta-analysis. World J Surg Oncol. 2020 Sep 21;18(1):251. doi: 10.1186/s12957-020-02018-z.</citation>
    <PMID>32958079</PMID>
  </reference>
  <reference>
    <citation>Boudjema K, Locher C, Sabbagh C, Ortega-Deballon P, Heyd B, Bachellier P, Métairie S, Paye F, Bourlier P, Adam R, Merdrignac A, Tual C, Le Pabic E, Sulpice L, Meunier B, Regimbeau JM, Bellissant E; METASYNC Study group. Simultaneous Versus Delayed Resection for Initially Resectable Synchronous Colorectal Cancer Liver Metastases: A Prospective, Open-label, Randomized, Controlled Trial. Ann Surg. 2021 Jan 1;273(1):49-56. doi: 10.1097/SLA.0000000000003848.</citation>
    <PMID>32209911</PMID>
  </reference>
  <reference>
    <citation>Gavriilidis P, Sutcliffe RP, Hodson J, Marudanayagam R, Isaac J, Azoulay D, Roberts KJ. Simultaneous versus delayed hepatectomy for synchronous colorectal liver metastases: a systematic review and meta-analysis. HPB (Oxford). 2018 Jan;20(1):11-19. doi: 10.1016/j.hpb.2017.08.008. Epub 2017 Sep 7.</citation>
    <PMID>28888775</PMID>
  </reference>
  <verification_date>December 2021</verification_date>
  <study_first_submitted>November 5, 2021</study_first_submitted>
  <study_first_submitted_qc>November 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 30, 2021</study_first_posted>
  <last_update_submitted>December 3, 2021</last_update_submitted>
  <last_update_submitted_qc>December 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Neoplasm Metastasis</mesh_term>
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

